Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Hao YaoDepartment of Breast Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.ORCID 0009-0000-8187-0523
Xuyang QianDepartment of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Ran ZhengDepartment of Breast Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Xingye ShengDepartment of Breast Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Jingjing DingDepartment of Breast Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Mingyu WangDepartment of Breast Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Xiaoming ZhaDepartment of Breast Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Shouju WangDepartment of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.ORCID 0000-0001-9213-6818
Jue WangDepartment of Breast Disease, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.ORCID 0000-0003-1683-5304
Funding
Bethune Research Foundation 2024-YJ-156-J-004China Breast Surgery Young Physician Research Award Advantage Support Program 2020-CHPASLP-01Chinese Society of Clinical Oncology Foundation Y-HR2020MS-0421Jiangsu Province Elderly Health Research Project LKM2022033, LKM2023023Wu Jieping Medical Foundation Special Fund for Clinical Research 320.6750.2023-11-29
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
breast neoplasmsErbB-2magnetic resonance imagingneoadjuvant therapyreceptor
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Early MRI-Derived Volumetric Thresholds Predict Response and Guide Personalization in HER2-Positive Breast Cancer: A Retrospective Study. · full record | OpenQuestion